MicroPort CardioFlow sees share capital increase after August option exercises

MicroPort CardioFlow Medtech Corporation announced an increase in its total number of issued shares by 85,000 to 2,412,706,775 as of August 31, 2025. This was primarily driven by the exercise of share options under its scheme approved on March 13, 2020. During the month, 85,000 new shares were issued from exercised options, while 90,000 options were cancelled.

The total funds raised from the exercise of options during August amounted to HK$105,400. As of the end of the month, the company's total authorized/registered share capital remained at $50,000, represented by 10,000,000,000 ordinary shares with a par value of $0.000005 each.

Outstanding share options under the March 13, 2020 scheme decreased from 56,076,742 to 55,901,742. Additionally, 26,428,062 options remain outstanding under a separate share scheme approved on June 27, 2023, with no movements reported for this scheme during the month.